AN2 Therapeutics ANTX
NASDAQ ANTX
$4.46 +0.13 (+3.00%)
At close: Nov 11, 2026 · 4:00 PM EST

AN2 Therapeutics (ANTX) Operating Leases (2022 - 2023)

Updated

Analysis

AN2 Therapeutics (ANTX) Operating Leases (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 AN2 Therapeutics 164.30 Mn -121.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 13,000.00
Mar 31, 2023 34,000.00
Dec 31, 2022 53,000.00
Sep 30, 2022 73,000.00
Jun 30, 2022 13,000.00
Mar 31, 2022 32,000.00
API Access

AN2 Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ANTX&period=max&api_key=YOUR_API_KEY